Overview of Craneware Plc’s Recent Position Disclosures
Craneware Plc, a notable player in the healthcare software space, remains committed to transparency regarding its stock positions. These disclosures are vital for investors who seek to understand the dynamics influencing their investment choices in the stock market.
Key Information About Craneware Plc
Disclosure Details
The key discloser is Rathbones Group Plc, which reveals insights into significant holdings in Craneware Plc. As a shareholder representing more than 1% of the relevant securities, detailing the ownership structure becomes paramount.
Recent Changes in Ownership
The latest position held was declared, showcasing a holding of 2,115,848 shares, representing approximately 5.97% ownership. Such significant proportions reflect Rathbones' robust commitment to Craneware Plc.
Positions Held by Discloser
Interests and Short Positions
In addition to the sizeable ownership stake, there are no reported short positions or other securities tied to Rathbones in their dealings. This signifies a strong confidence in Craneware’s performance and future direction.
Disclosure of Derivative Transactions
It is important for investors to note that cash-settled derivatives were not indicated in the latest report. This offers a clearer picture of Rathbones’ straightforward approach to dealing with Craneware’s equities, prioritizing direct stock ownership.
Recent Dealings by Rathbones
Purchases and Sales Overview
Among the notable transactions, a sale of 330 shares was executed at a price of 2008p per share. This indicates a strategic move within their larger portfolio management plans, sourcing liquidity as necessary while maintaining a substantial stake in Craneware's equities.
Additional Dealings and Securities Management
There are no reports of other dealings or significant transactions such as subscription for new securities, showcasing a focused investment strategy directed toward solidifying their existing position in Craneware Plc. The decision to only report significant trades demonstrates a calculated approach to investment disclosures.
Other Relevant Information Regarding Disclosures
Indemnity and Agreements
Concerning indemnities or other arrangements that could influence dealings, Rathbones reported no existing agreements that may induce or affect trading decisions. This further underlines an ethical trading approach, providing investors with confidence in the transparency of the practices employed.
Future Perspectives
As Craneware Plc expands and evolves within the rapidly changing healthcare technology landscape, continuous updates are essential. Investors can keep an eye on future disclosures from Rathbones Group Plc, reflecting their ongoing confidence and perspective on Craneware’s business trajectory and market conditions.
Frequently Asked Questions
What is Craneware Plc known for?
Craneware Plc focuses on delivering software solutions for the healthcare sector, enhancing efficiency and financial management.
Who disclosed the recent information about Craneware Plc?
The recent disclosures were made by Rathbones Group Plc, indicating their significant holdings in Craneware.
What was the percentage of ownership by Rathbones?
Rathbones holds approximately 5.97% of Craneware Plc's shares.
Were any derivative transactions reported in the disclosure?
No cash-settled or stock-settled derivative transactions were reported in connection with the latest disclosures.
How can I contact Craneware Plc?
For any inquiries, Chinwe Enyi from the Compliance Department can be reached at 0151 243 7053.
